Cenicriviroc
Cenicriviroc (TAK-652) is an orally bioavailable dual CCR2 and CCR5 antagonist. It exhibits anti-HIV-1/2 activity and has been investigated in research for its anti-inflammatory effects in models of liver and kidney fibrosis, both in vitro and in vivo.
Product Specifications
CAS Number
497223-25-3
Product Name Alternative
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
97.87% (May vary between batches)
Solubility
DMSO:120 mg/mL (172.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (5.74 mM)
Smiles
CC (C) CN1CCC/C (C (NC2=CC=C ([S@] (CC3=CN=CN3CCC) =O) C=C2) =O) =C\C4=CC (C5=CC=C (OCCOCCCC) C=C5) =CC=C41
Molecular Formula
C41H52N4O4S
Molecular Weight
696.94
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human CCR9 Alexa Fluor 750 MAb (Clone 248621R)
TRNAG6 CRISPR All-in-one AAV vector set (with saCas9)(Human)
